Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Does white coat hypertension require treatment over age 80?: Results of the hypertension in the very elderly trial ambulatory blood pressure side project.

Bulpitt CJ, Beckett N, Peters R, Staessen JA, Wang JG, Comsa M, Fagard RH, Dumitrascu D, Gergova V, Antikainen RL, Cheek E, Rajkumar C.

Hypertension. 2013 Jan;61(1):89-94. doi: 10.1161/HYPERTENSIONAHA.112.191791. Epub 2012 Nov 19.

2.

Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial.

Peters R, Beckett N, Forette F, Tuomilehto J, Clarke R, Ritchie C, Waldman A, Walton I, Poulter R, Ma S, Comsa M, Burch L, Fletcher A, Bulpitt C; HYVET investigators.

Lancet Neurol. 2008 Aug;7(8):683-9. doi: 10.1016/S1474-4422(08)70143-1. Epub 2008 Jul 7.

3.

Hypertension in the Very Elderly Trial (HYVET): protocol for the main trial.

Bulpitt C, Fletcher A, Beckett N, Coope J, Gil-Extremera B, Forette F, Nachev C, Potter J, Sever P, Staessen J, Swift C, Tuomilehto J.

Drugs Aging. 2001;18(3):151-64.

PMID:
11302283
4.

Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.

Mallion JM, Chamontin B, Asmar R, De Leeuw PW, O'Brien E, Duprez D, O'Rourke MF, Rahn KH, Romero R, Battegay E, Hitzenberger G, Safar ME; REASON Project.

Am J Hypertens. 2004 Mar;17(3):245-51.

PMID:
15001199
5.

HYVET ambulatory blood pressure substudy.

Ben-Dov IZ, Bursztyn M.

Hypertension. 2013 May;61(5):e42. doi: 10.1161/HYPERTENSIONAHA.111.00884. Epub 2013 Mar 4. No abstract available.

6.

Response to HYVET ambulatory blood pressure substudy.

Bulpitt CJ, Beckett N, Peters R, Staessen JA.

Hypertension. 2013 May;61(5):e43. No abstract available.

7.

Effects of blood pressure lowering on major vascular events among patients with isolated diastolic hypertension: the perindopril protection against recurrent stroke study (PROGRESS) trial.

Arima H, Anderson C, Omae T, Woodward M, Hata J, Murakami Y, Macmahon S, Neal B, Chalmers J; PROGRESS Collaborative Group.

Stroke. 2011 Aug;42(8):2339-41. doi: 10.1161/STROKEAHA.110.606764. Epub 2011 Jun 23.

8.

Blood pressure control in the Hypertension in the Very Elderly Trial (HYVET).

Bulpitt CJ, Beckett NS, Peters R, Leonetti G, Gergova V, Fagard R, Burch LA, Banya W, Fletcher AE.

J Hum Hypertens. 2012 Mar;26(3):157-63. doi: 10.1038/jhh.2011.10. Epub 2011 Mar 10.

PMID:
21390056
9.

Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to Hypertension in the Very Elderly randomised controlled trial.

Beckett N, Peters R, Tuomilehto J, Swift C, Sever P, Potter J, McCormack T, Forette F, Gil-Extremera B, Dumitrascu D, Staessen JA, Thijs L, Fletcher A, Bulpitt C; HYVET Study Group.

BMJ. 2011 Jan 4;344:d7541. doi: 10.1136/bmj.d7541.

10.

Effect of slow-release indapamide and perindopril compared with amlodipine on 24-hour blood pressure and left ventricular mass in hypertensive patients of African ancestry.

Libhaber EN, Libhaber CD, Candy GP, Sliwa K, Kachope J, Hlatshwayo NM, Puane MO, Woodiwiss AJ, Norton GR, Essop MR, Sareli P.

Am J Hypertens. 2004 May;17(5 Pt 1):428-32.

PMID:
15110902
11.

Persistence of the antihypertensive effect of low-dose combination therapy in mild hypertension.

Myers MG, Leenen FH; General Practice Research Group.

Blood Press. 2006;15(6):325-32.

PMID:
17472022
12.

[Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].

Amado P, Vasconcelos N, Santos I, Almeida L, Nazaré J, Carmona J.

Rev Port Cardiol. 1999 Oct;18(10):897-906. Portuguese.

PMID:
10590654
14.

Effects of delapril in combination with indapamide on blood pressure and left ventricular mass in elderly hypertensive patients.

Acanfora D, Lowenthal DT, Furgi G, Trojano L, Picone C, Nicolino A, Iannuzzi GL, Papa A, Rengo F.

Am J Ther. 1998 Jan;5(1):17-23.

PMID:
10099033
15.

Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.

Palatini P, Dorigatti F, Mugellini A, Spagnuolo V, Varì N, Ferrara R, Bertocchi F.

Clin Ther. 2004 Sep;26(9):1436-45.

PMID:
15531006
16.

Disproportional decrease in office blood pressure compared with 24-hour ambulatory blood pressure with antihypertensive treatment: dependency on pretreatment blood pressure levels.

Schmieder RE, Schmidt ST, Riemer T, Dechend R, Hagedorn I, Senges J, Messerli FH, Zeymer U.

Hypertension. 2014 Nov;64(5):1067-72. doi: 10.1161/HYPERTENSIONAHA.113.03140. Epub 2014 Aug 4.

19.

Efficacy of single-pill perindopril/indapamide in patients with hypertension and type 2 diabetes.

Netchessova TA, Shepelkevich AP, Gorbat TV; NIKA Study Group.

High Blood Press Cardiovasc Prev. 2014 Mar;21(1):63-9. doi: 10.1007/s40292-013-0036-x. Epub 2013 Dec 20.

PMID:
24357222
20.

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.

Patel A; ADVANCE Collaborative Group, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N, Marre M, Cooper M, Glasziou P, Grobbee DE, Hamet P, Heller S, Liu LS, Mancia G, Mogensen CE, Pan CY, Rodgers A, Williams B.

Lancet. 2007 Sep 8;370(9590):829-40.

PMID:
17765963
Items per page

Supplemental Content

Write to the Help Desk